Mechanism of Abeta Accumulation Induced Synaptic Dysfunction in AD

Principal Investigator
Gunnar Gouras, MD
Weill Medical College of Cornell University
New York, NY, United States
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2005 - March 31, 2008
Grant ID
A2005064
Summary
Dr. Gouras is looking to better understand how accumulation of beta-amyloid within nerve cells may lead to the characteristic synaptic dysfunction and degeneration of nerve cell processes that occur in Alzheimer’s disease. Recent evidence has indicated that the transport of the precursor of beta-amyloid is important in the disease process, and that nerve cell activity promotes beta-amyloid secretion. Given that accumulation of beta-amyloid may be quite important for the development of the disease, Dr. Gouras’ experiments plan to elucidate the biological mechanism by which synaptic activity alters beta-amyloid, and to better define how beta-amyloid accumulation within nerve cells may be involved in the disease. The ultimate aim of this experiment is to help in devising novel therapies for Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine